IriflophenoneCAS# 52591-10-3 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 52591-10-3 | SDF | Download SDF |
| PubChem ID | 11311158 | Appearance | Yellow powder |
| Formula | C13H10O5 | M.Wt | 246.2 |
| Type of Compound | Xanthones | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (4-hydroxyphenyl)-(2,4,6-trihydroxyphenyl)methanone | ||
| SMILES | C1=CC(=CC=C1C(=O)C2=C(C=C(C=C2O)O)O)O | ||
| Standard InChIKey | AOJWDTJDEGSHOA-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C13H10O5/c14-8-3-1-7(2-4-8)13(18)12-10(16)5-9(15)6-11(12)17/h1-6,14-17H | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Targets | Estrogen receptor | Progestogen receptor |
Iriflophenone Dilution Calculator
Iriflophenone Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 4.0617 mL | 20.3087 mL | 40.6174 mL | 81.2348 mL | 101.5435 mL |
| 5 mM | 0.8123 mL | 4.0617 mL | 8.1235 mL | 16.247 mL | 20.3087 mL |
| 10 mM | 0.4062 mL | 2.0309 mL | 4.0617 mL | 8.1235 mL | 10.1543 mL |
| 50 mM | 0.0812 mL | 0.4062 mL | 0.8123 mL | 1.6247 mL | 2.0309 mL |
| 100 mM | 0.0406 mL | 0.2031 mL | 0.4062 mL | 0.8123 mL | 1.0154 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Neophellamuretin
Catalog No.:BCN7888
CAS No.:52589-20-5
- Phellamurin
Catalog No.:BCN5678
CAS No.:52589-11-4
- Acm-thiopropionic acid
Catalog No.:BCC2838
CAS No.:52574-08-0
- Glycozolinine
Catalog No.:BCN5677
CAS No.:5257-08-9
- bPiDDB
Catalog No.:BCC7606
CAS No.:525596-66-1
- Ingenol 3-palmitate
Catalog No.:BCN7686
CAS No.:52557-26-3
- Pranoprofen
Catalog No.:BCC4828
CAS No.:52549-17-4
- 5,7-Dihydroxychromone 7-rutinoside
Catalog No.:BCN3333
CAS No.:52538-46-2
- Quercetin 3-O-robinobioside
Catalog No.:BCN5676
CAS No.:52525-35-6
- Flavone
Catalog No.:BCN8477
CAS No.:525-82-6
- Kinetin
Catalog No.:BCC1679
CAS No.:525-79-1
- Harmalol
Catalog No.:BCC8183
CAS No.:525-57-5
- Eudesmin
Catalog No.:BCN6563
CAS No.:526-06-7
- Sesamolin
Catalog No.:BCN1289
CAS No.:526-07-8
- Abrine
Catalog No.:BCN2348
CAS No.:526-31-8
- Tryptophol
Catalog No.:BCN5681
CAS No.:526-55-6
- Isoretronecanol
Catalog No.:BCN1993
CAS No.:526-63-6
- Trachelanthamidine
Catalog No.:BCN1991
CAS No.:526-64-7
- D(-)-Tartaric acid
Catalog No.:BCN8460
CAS No.:526-83-0
- Conduritol A
Catalog No.:BCN5683
CAS No.:526-87-4
- H-Sar-OEt.HCl
Catalog No.:BCC3334
CAS No.:52605-49-9
- Epipterosin L
Catalog No.:BCN5680
CAS No.:52611-75-3
- Deacetylasperulosidic acid methyl ester
Catalog No.:BCN1427
CAS No.:52613-28-2
- Ponicidin
Catalog No.:BCN3231
CAS No.:52617-37-5
Effects of iriflophenone 3-C-beta-glucoside on fasting blood glucose level and glucose uptake.[Pubmed:25709215]
Pharmacogn Mag. 2015 Jan-Mar;11(41):82-9.
BACKGROUND: One of the biological activities of agar wood (Aquilaria sinensis Lour., Thymelaeaceae), is anti-hyperglycemic activity. The methanolic extract (ME) was proven to possess the fasting blood glucose activity in rat and glucose uptake transportation by rat adipocytes. OBJECTIVE: To determine the decreasing fasting blood glucose level of constituents affordable for in vivo test. If the test was positive, the mechanism which is positive to the ME, glucose transportation, will be performed. MATERIALS AND METHODS: The ME was separated by column chromatography and identified by spectroscopic methods. Mice was used as an animal model (in vivo), and rat adipocytes were used for the glucose transportation activity (in vitro). RESULT: Iriflophenone 3-C-beta-glucoside (IPG) was the main constituent, 3.17%, and tested for the activities. Insulin and the ME were used as positive controls. The ME, IPG and insulin lowered blood glucose levels by 40.3, 46.4 and 41.5%, respectively, and enhanced glucose uptake by 152, 153, and 183%, respectively. CONCLUSION: These findings suggest that IPG is active in lowering fasting blood glucose with potency comparable to that of insulin.
Assessment of extraction parameters on antioxidant capacity, polyphenol content, epigallocatechin gallate (EGCG), epicatechin gallate (ECG) and iriflophenone 3-C-beta-glucoside of agarwood (Aquilaria crassna) young leaves.[Pubmed:25153858]
Molecules. 2014 Aug 14;19(8):12304-19.
The effects of ethanol concentration (0%-100%, v/v), solid-to-solvent ratio (1:10-1:60, w/v) and extraction time (30-180 min) on the extraction of polyphenols from agarwood (Aquilaria crassna) were examined. Total phenolic content (TPC), total flavonoid content (TFC) and total flavanol (TF) assays and HPLC-DAD were used for the determination and quantification of polyphenols, flavanol gallates (epigallocatechin gallate--EGCG and epicatechin gallate--ECG) and a benzophenone (Iriflophenone 3-C-beta-glucoside) from the crude polyphenol extract (CPE) of A. crassna. 2,2'-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity was used to evaluate the antioxidant capacity of the CPE. Experimental results concluded that ethanol concentration and solid-to-solvent ratio had significant effects (p<0.05) on the yields of polyphenol and antioxidant capacity. Extraction time had an insignificant influence on the recovery of EGCG, ECG and Iriflophenone 3-C-beta-glucoside, as well as radical scavenging capacity from the CPE. The extraction parameters that exhibited maximum yields were 40% (v/v) ethanol, 1:60 (w/v) for 30 min where the TPC, TFC, TF, DPPH, EGCG, ECG and Iriflophenone 3-C-beta-glucoside levels achieved were 183.5 mg GAE/g DW, 249.0 mg QE/g DW, 4.9 mg CE/g DW, 93.7%, 29.1 mg EGCG/g DW, 44.3 mg ECG/g DW and 39.9 mg Iriflophenone 3-C-beta-glucoside/g DW respectively. The IC50 of the CPE was 24.6 mg/L.
